Chin Peter Scott sold DNLI

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002124755-26-000007

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 4, 2026

Published

Sep 9, 2026

Ingested by INSIDER

Nov 5, 02:18 UTC

Last re-read

Nov 5, 02:18 UTC

Extracted facts

Filer

Chin Peter Scott

Role

Chief Medical Officer

Transaction

Open-market saleAs filed: “S”

Asset

Denali Therapeutics Inc.

Ticker

DNLI

Shares

1,654

Price per share

$22.29

Value

$36,868

Execution date (reported)

Sep 4, 2026

Owned after transaction

204.5K shares

Days from execution to publication

5

Calculation

What this establishes

Chin Peter Scott filed this Form 4 reporting a open-market sale of DNLI on Sep 4, 2026. It became public on Sep 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Chin Peter Scottcik:0002124755

Issuer

Denali Therapeutics Inc.cik:0001714899

Revision history · 0

No field has changed since this record was first ingested.